Research suggests that the swine flu outbreak of winter 2009-2010 was more widespread than previously realized, with almost half of Scottish adults carrying antibodies to the virus. The study found that people from deprived areas were twice as likely to contract the virus.
The destruction of live smallpox samples is crucial for further research, as the last naturally occurring case occurred in 1977. New vaccines have been developed, but full development is essential for global security and public health.
Humanized BLT mice, created with human bone marrow, liver, and thymus tissues, have been shown to reproduce the design of a recent clinical study on topical microbicide tenofovir. The results demonstrate 88% protection against vaginal HIV transmission, warranting consideration for future testing in people.
Researchers identified characteristic patterns of molecules called microRNA (miRNA) in the blood of people with lung cancer that may reveal its presence and aggressiveness. These patterns could potentially lead to a blood test for early detection, even up to two years before tumor formation.
Researchers at the University of Utah Health conducted a comprehensive study finding no evidence of XMRV in CFS patients or healthy controls. The study's results contradict previous findings that linked the retrovirus to CFS, and experts emphasize the need for further research into potential infectious agents associated with the disease.
A study published in the Journal of Neuroscience reveals that social stress can increase inflammation among brain cells, leading to anxiety-like behaviors. The researchers found that immune cells migrated to the brain in response to social stress, triggering an inflammatory response and a specific activation pattern of neurons.
Researchers identified a genetic mutation causing fatal developmental disease MOPD1, affecting fetal growth and brain development. The mutation is prevalent in the Ohio Amish population, with approximately 6% prevalence.
A team of researchers from Rockefeller University has carried out a comprehensive evaluation of the antiviral activity of interferon-induced factors, revealing unique subsets of genes that inhibit various viruses. The study found that specific combinations of genes can be more potent than individual ones in suppressing viral replication.
Stark's contributions span biochemistry, gene regulation and cell signaling, influencing immunity and cancer research. He is recognized for developing Northern and Western techniques widely used in research and clinical applications.
Researchers found that HIV requires base excision repair proteins to integrate its DNA into the host genome, identifying novel targets for anti-HIV drugs. The study suggests that drugs targeting these cellular proteins may avoid resistance and have fewer side effects.
A gene therapy called NLX-P101 significantly reduces movement impairment in Parkinson's patients, with half achieving dramatic symptom improvements. The treatment introduces a gene to normalize chemical signaling, correcting dysfunction in brain circuitry responsible for coordinating movement.
Researchers have developed an experimental vaccine against the human norovirus, generating a strong immune response in mice. The vaccine uses a novel viral vector-based method and showed promise in inducing high levels of antibodies and a robust white blood cell response in animals.
Researchers at the University of Copenhagen have developed a new vaccine technology that stimulates and accelerates the immune system to show its defense mechanisms against hepatitis C virus. The technology works by presenting a larger section of the internal molecule, allowing the immune defenses to recognize and respond to it.
A new study has successfully trialed a synthetic universal flu vaccine in mice, providing 100% protection against the H3N2 strain and 20% against the highly pathogenic bird flu. The vaccine uses peptides that trigger an immune response to a region of the flu virus present in all influenza A and B viruses.
Researchers at the Trudeau Institute and St. Jude Children's Research Hospital are studying white blood cell migration in response to viral infections, which could lead to improved vaccine strategies. The study has major implications for developing vaccines that promote immunity to respiratory infections.
Researchers have successfully developed genetically modified chickens that do not transmit avian influenza virus to other chickens, potentially stopping bird flu outbreaks within poultry flocks. This genetic modification has the potential to reduce the risk of bird flu epidemics leading to new flu virus epidemics in humans.
Researchers at Ohio State University have identified a link between PI3K/AKT signaling and epigenetic silencing in breast cancer. Combining an agent that inhibits PI3K with a drug that reverses gene silencing significantly slows tumor growth, suggesting a new approach for treating the disease.
A new study aims to shut down the viral assembly line of coronaviruses, a process crucial for their replication. The research focuses on the M protein, which forms the outer shell of the virus and is critical for its pathogenesis.
Researchers found that the core protein interacts with non-structural helicase protein, playing a critical role in viral replication. This new understanding supports a potential new therapeutic target for hepatitis C drug development and may prevent production of infectious viral particles.
A new cell-based assay system, EASY-HIT, has been developed to identify HIV inhibitors and measure their potency. The technology, led by Professor Ruth Brack-Werner, can also detect anti-HIV activities in raw plant extracts and has already discovered novel sources of antiviral activities.
Researchers from Boston University School of Medicine have identified a mechanism by which specific viruses acting as oncolytic agents can enter and kill cancer cells. By targeting the AKT signaling pathway, VSV is able to switch off a major cell survival signal, leaving cancer cells vulnerable to attack.
Researchers at Gladstone Institute of Virology and Immunology discover how HIV promotes the death of CD4 T cells by infecting them with a failed form of viral replication. This process leads to the depletion of these critical immune cells, ultimately causing AIDS.
Researchers have found that the HIV virus triggers an immune response in CD4 T cells due to incomplete reverse transcription, leading to cell death. The study's findings suggest that targeting the cell sensor responsible for this response could lead to new treatment strategies.
A team of researchers identified the gene Trib1 in mice, which regulates lipid production by the liver. Overexpression of Trib1 decreased blood lipids, while lack of Trib1 increased them. This suggests that TRIB1 is responsible for associations between chromosome 8 and lipid levels.
Researchers have identified key molecules in multiple myeloma that can trigger expression of the P53 tumor suppressor gene, slowing cell growth and leading to death. The study suggests re-activating these microRNAs could provide a new treatment strategy for the disease.
Researchers have discovered the world's largest marine virus, Cafeteria roenbergensis virus, which has a genome larger than some cellular organisms. This complex 'mimi-like' virus infects an ecologically important planktonic predator and challenges the traditional boundary between living and non-living entities.
A variant of last year's pandemic influenza linked to fatal cases carried a mutation that enabled it to infect a different subset of cells lining the airway, impairing the lungs' clearing mechanism. The study suggests that this mutant virus could have made the illness more severe and fatal.
Dr. Douglas A. Jabs has been recognized by the American Academy of Ophthalmology with the Jackson Memorial Lecture for his decades-long study on cytomegalovirus retinitis and its interaction with HIV. His research aims to improve clinical outcomes in patients with AIDS and CMV retinitis.
Researchers found that an enzyme associated with fat storage in liver cells is required for HCV infectious activity. DGAT1 inhibitors may be effective against HCV, with several already in early clinical trials to treat obesity-associated diseases.
Dr. Verdin's research aims to develop a new single cell technology to examine HIV latency, with the goal of devising novel strategies to eliminate latent HIV infection or restrict its pool to a size that can be controlled by the immune system.
Researchers at Helmholtz Zentrum Muenchen and TU Muenchen used NMR spectroscopy to determine the spatial structure of Sam68's Qua1 region, essential for dimerization and biological function. The study sheds light on Sam68's role in cell cycle regulation and cancer pathogenesis.
A study published in Eurosurveillance found that nearly 60% of Norway's population had measurable immunity to the pandemic H1N1 virus by January 2010. Vaccination and infection contributed to this increased immunity, with herd immunity also playing a role.
Scientists have identified six critical amino acids in the TRIM5α protein that enable it to destroy HIV. Altering these amino acids in human cells renders TRIM5α ineffective against HIV-1 infection, highlighting a potential target for therapy development.
Researchers at the University of Minnesota have identified two FDA-approved drugs, decitabine and gemcitabine, which, when combined, may be an effective treatment for HIV. The drug combination forces the virus to mutate itself to death, a phenomenon dubbed 'lethal mutagenesis.'
Scientists at the University of Cambridge have developed a vaccine to stop cancer-causing viruses that invade host cells, initiate cancer, and then disappear. The vaccine has been shown to protect against subsequent cancer development in mouse models, holding promise for preventing human cancers.
A new HIV drug candidate called PIE12-trimer has been developed by a University of Utah biochemist, which prevents the virus from attacking human cells. The compound is designed with a unique resistance capacitor that makes it effective against emerging drug-resistant viruses.
A new study found that childhood abuse can lead to a weakened immune system later in life, with participants who experienced adverse experiences showing higher levels of stress markers. Additionally, caregivers who had been abused as children showed significantly shorter telomere length than non-caregivers.
Benjamin tenOever, a leading expert in microbiology and infectious diseases, has been awarded the 2010 ICAAC Young Investigator Award. His research focuses on understanding the cell's response to infection and developing novel strategies for vaccine and antiviral drug design.
A recent study by The Wistar Institute found that the newly identified human adenovirus AdHu26 commonly infects people, particularly those in Sub-Saharan Africa, rendering it an unlikely candidate as a vaccine carrier. In contrast, chimpanzee adenoviruses demonstrate similar functionality and are considered superior for mass vaccination.
Researchers at Ohio State University found that breast cancer cells can regulate 14 genes simultaneously in response to estrogen-like compounds like BPA. This mechanism may contribute to cancer development and could serve as a marker for studying environmental exposure.
A new study found that an enriched environment can reduce cancer growth in mice by activating a nervous system pathway that decreases leptin levels, a hormone linked to appetite and cancer growth. The effect was observed in models of melanoma and colon cancer, with tumors reduced by up to 80% after three weeks of enrichment.
The Fogarty International Center of the NIH has awarded a five-year, $3.6 million grant to an international AIDS training and research program to continue training foreign researchers in developing countries. The program supports established research training programs in India, Cambodia, the Philippines, and Kenya, and will also focus ...
Scientists at TWINCORE have developed a mouse-adapted version of the hepatitis C virus, allowing researchers to study its interaction with the immune system. This breakthrough enables the development of new vaccines and treatments for this chronic infection.
A recent study found that the original HIV strain still exists in the body months after initial infection, with immune cells degrading it at an accelerated rate. The research analyzed over 100,000 genetic snippets and revealed that the virus mutates rapidly to evade the immune system, but certain portions remain persistent.
Dr. George Stark receives prestigious lectureship for outstanding lifetime scientific contributions, spanning basic biochemistry and specialized fields like gene regulation and cell signaling.
Researchers have identified eIF5A as a crucial player in pancreatic beta cell dysfunction in diabetes. Blocking hypusine modification of eIF5A protected mice in a model of diabetes, suggesting potential therapeutics for preserving beta cell function.
The Baylor College of Medicine team has successfully sequenced 178 microbial reference genomes representative of the human body. These reference genomes will help scientists understand and contextualize the data accumulated over time, providing valuable insights into the complex relationship between humans and their microbiota.
Scientists have developed an immune-deficient mouse model to study CCHF virus behavior in humans, a significant step towards vaccine and antiviral development. The model can help evaluate the safety and effectiveness of potential treatments, addressing the lack of suitable animal models for testing.
A new study reveals that cancer cells' miRNA networks are rewired and fragmented, with small clusters of two to six miRNAs existing outside the main network. This finding suggests a new approach to identifying cancer genes and targets for drug development.
Researchers at Ohio State University discovered that microRNA-155 can silence genes protecting against DNA mutations, contributing to cancer progression. The study suggests miR-155 expression may be a key stratification factor in cancer prognosis and treatment.
Researchers discovered specific PTEN mutations linked to distinct kinds of cancer in organs targeted by Cowden syndrome. The study suggests that testing for these mutations could predict cancer severity in patients with the syndrome.
Computer modeling and systems biology approaches can help tailor treatments to individuals, predicting disease progression and identifying host genes that affect viral development. This approach may lead to more effective treatment, detection, and prevention of future pandemics.
A study published in Cell reveals that loss of the molecule miR-328 is essential for progression from chronic to blast crisis phase in chronic myeloid leukemia. Maintaining this microRNA level may represent a new treatment strategy for CML blast crisis patients.
Researchers at the Gladstone Institutes discovered that SIRT3 plays a crucial role in regulating fatty acid oxidation and identified it as a potential therapeutic target. Mice lacking SIRT3 exhibited impaired fat burning and increased levels of fat and triglycerides, highlighting the enzyme's importance in energy metabolism.
A new study found that typhoid fever bacteria form persistent communities on gallstones, making carriers particularly hard to treat. The infection is transmitted through fecal-oral contact and can lead to hundreds of thousands of deaths worldwide each year.
Researchers identified specific mutations that enable a common plant virus to infect new species, shedding light on the viral-host interface. The study's findings could inform strategies for breeding resistant crops and understanding animal disease emergence.
Physicist Alex Evilevitch directly measured the energy associated with viral DNA expulsion, a discovery that could lead to broad-spectrum antiviral drugs. The study used isothermal titration calorimetry and found that increasing DNA length increases heat release, highlighting the importance of hydration entropy in viral genome packaging.
Researchers at Medical College of Georgia have discovered celastrol's potential to target cancer cells by inhibiting the heat shock protein 90. Celastrol induces protein clustering, which inactivates it, helping to reduce cancer growth. Future studies aim to use more potent derivatives in combination with other therapeutic agents.
Scientists tested 2009 and 1918 H1N1 virus strains on chickens and ducks without causing disease or symptoms. The results suggest that birds played no role in the spread of these pandemic viruses.
Researchers developed a rapid-acting disinfectant that kills bacteria, viruses and fungi on surgical instruments, including those resistant to conventional disinfectants. The new formula is safer, cheaper and more effective than existing treatments against prions, which cause deadly illnesses.